| D008297 |
Male |
|
Males |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000293 |
Adolescent |
A person 13 to 18 years of age. |
Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths |
|
| D001321 |
Autistic Disorder |
A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V) |
Autism, Infantile,Kanner's Syndrome,Autism,Autism, Early Infantile,Disorder, Autistic,Disorders, Autistic,Early Infantile Autism,Infantile Autism,Infantile Autism, Early,Kanner Syndrome,Kanners Syndrome |
|
| D016728 |
Self-Injurious Behavior |
Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation. |
Intentional Self Harm,Intentional Self Injury,Self Harm,Self-Destructive Behavior,Deliberate Self-Harm,Non-Suicidal Self Injury,Nonsuicidal Self Injury,Self-Injury,Behavior, Self-Destructive,Behavior, Self-Injurious,Deliberate Self Harm,Harm, Self,Intentional Self Injuries,Non Suicidal Self Injury,Non-Suicidal Self Injuries,Nonsuicidal Self Injuries,Self Destructive Behavior,Self Harm, Intentional,Self Injurious Behavior,Self Injury,Self Injury, Intentional,Self Injury, Non-Suicidal,Self Injury, Nonsuicidal,Self-Destructive Behaviors,Self-Harm, Deliberate,Self-Injurious Behaviors |
|
| D016896 |
Treatment Outcome |
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. |
Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes |
|
| D017374 |
Paroxetine |
A serotonin uptake inhibitor that is effective in the treatment of depression. |
Aropax,BRL-29060,FG-7051,Paroxetine Acetate,Paroxetine Hydrochloride,Paroxetine Hydrochloride Anhydrous,Paroxetine Hydrochloride Hemihydrate,Paroxetine Hydrochloride, Hemihydrate,Paroxetine Maleate,Paroxetine, cis-(+)-Isomer,Paroxetine, cis-(-)-Isomer,Paroxetine, trans-(+)-Isomer,Paxil,Seroxat,BRL 29060,BRL29060,FG 7051,FG7051 |
|